Drug prices need to achieve their current levels to maintain ongoing bio-pharma innovation and access.
Read MoreKevin Schulman, Clinical Excellence Research Center, Stanford University: An analysis of the impact of moral hazard on pharmaceutical prices – and the implications for policy makers.
Read MoreJennifer Ohn and Anna Kaltenboeck, Memorial Sloan Kettering Cancer Center: Rising specialty drug costs highlight the need for an alternative pricing system that incorporates value for innovation.
Read MoreDavid Wohlever Sánchez, Jackie Xu, and Qiang Zhang, Duke University: Why are U.S. drug prices so high? A breakdown of the U.S. healthcare system and prescription drug costs.
Read More
On behalf of the editorial team (Regina Herzlinger, Kevin Schulman, Lawrence Van Horn, and myself), I am delighted to welcome you to the current issue of HMPI. We are proud to publish another strong set of articles that help advance HMPI’s vision: We draw from the research and experience of scholars and practicing leaders to provide insights for public and private health sector organizations around the world. This issue kicks off with a set of articles about a question that has huge topical importance: drug prices in the U.S. and elsewhere. This question never lurks far below the surface of political and industry discourse and the current U.S. administration is considering multiple initiatives that would rein in what it believes are excessive prices. Read more
Top of mind are healthcare policy, insurance access, value-based purchasing, and the opioid epidemic.
Read more
Adverse events happen in obstetrics. How can hospitals transform Labor & Delivery units so they rarely occur?
Read more
The balance between the global and the local is transforming opportunities and raising challenges.
Read more
In contrast to traditional criminal approaches, CEASE treats opioid use as a contagious disease.
Read more
A leadership development program suggests an impactful design for developing clinical and non-clinical leaders.
Read more
This study finds that providers offer both Medicaid enrollees and the privately ensured the same operational services.
Read more
But team-based approaches to health care delivery promise to reduce costs while maintaining quality.
Read more